|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-1-22
|
|
pubmed:abstractText |
The purpose of this study was to investigate the co-expression of survivin, c-erbB2, and COX-2 in endometrial cancer tissues and evaluate its prognostic significance in endometrial cancer
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1432-1335
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
136
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
427-35
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19756737-Adult,
pubmed-meshheading:19756737-Aged,
pubmed-meshheading:19756737-Aged, 80 and over,
pubmed-meshheading:19756737-Carcinoma,
pubmed-meshheading:19756737-Case-Control Studies,
pubmed-meshheading:19756737-Cyclooxygenase 2,
pubmed-meshheading:19756737-Endometrial Neoplasms,
pubmed-meshheading:19756737-Female,
pubmed-meshheading:19756737-Follow-Up Studies,
pubmed-meshheading:19756737-Humans,
pubmed-meshheading:19756737-Inhibitor of Apoptosis Proteins,
pubmed-meshheading:19756737-Microtubule-Associated Proteins,
pubmed-meshheading:19756737-Middle Aged,
pubmed-meshheading:19756737-Neoplasm Staging,
pubmed-meshheading:19756737-Predictive Value of Tests,
pubmed-meshheading:19756737-Prognosis,
pubmed-meshheading:19756737-Receptor, erbB-2,
pubmed-meshheading:19756737-Survival Analysis
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Co-expression of survivin, c-erbB2, and cyclooxygenase-2 (COX-2): prognostic value and survival of endometrial cancer patients.
|
|
pubmed:affiliation |
Laboratory of Histology-Embryology, Democritus University of Thrace, 68 100, Alexandroupolis, Greece.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
